{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-15T07:58:11.393683+00:00","company":{"ticker":"NHC","cik":1047335,"company_name":"NATIONAL HEALTHCARE CORP"},"pagination":{"limit":100,"returned":37,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Bank of America, N.A., as administrative agent, swingline lender and issuer of letters of credit","detail":"credit_facility","count":1,"first_seen":"2026-05-27T21:13:25+00:00","last_seen":"2026-05-27T21:13:25+00:00","evidence_fact_ids":[85584]},{"display_name":"National Health Corporation","detail":"asset_purchase","count":1,"first_seen":"2026-05-15T20:04:37+00:00","last_seen":"2026-05-15T20:04:37+00:00","evidence_fact_ids":[102015]},{"display_name":"National Health Investors, Inc.","detail":"asset_purchase","count":1,"first_seen":"2026-04-22T23:59:59+00:00","last_seen":"2026-04-22T23:59:59+00:00","evidence_fact_ids":[23565]},{"display_name":"Pinnacle Bank","detail":"credit_facility","count":1,"first_seen":"2023-05-11T23:59:59+00:00","last_seen":"2023-05-11T23:59:59+00:00","evidence_fact_ids":[153336]}],"lender":[{"display_name":"Bank of America, N.A.","detail":"term_loan","count":2,"first_seen":"2026-05-27T21:13:25+00:00","last_seen":"2026-05-27T21:13:25+00:00","evidence_fact_ids":[54672,54673]}],"ma_counterparty":[{"display_name":"White Oak Manor, Inc., its corporate subsidiaries, White Oak Pharmacy, Inc., and the other Seller Parties","detail":"acquisition","count":1,"first_seen":"2024-08-06T23:59:59+00:00","last_seen":"2024-08-06T23:59:59+00:00","evidence_fact_ids":[122215]}]},"facts":[{"fact_type":"material_agreement","fact_key":"8cddb5e9fa3ecba1a879949492ceb70b1fd72d29","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-27T21:13:25+00:00","payload":{"action":"entry","agreement_name":"Credit Agreement","agreement_type":"credit_facility","counterparty":"Bank of America, N.A., as administrative agent, swingline lender and issuer of letters of credit","effective_date":"2026-05-26","item_codes_triggered":["1.01"],"value_text":"$475.0 million senior unsecured term loan facility and a $50.0 million senior unsecured revolving cr"},"claim":"NATIONAL HEALTHCARE CORP entered into Credit Agreement with Bank of America, N.A., as administrative agent, swingline lender and issuer of letters of credit valued at $475.0 million senior unsecured term loan facility and a $50.0 million senior unsecured revolving cr (effective 2026-05-26).","evidence_excerpt":"On May 26, 2026, National HealthCare Corporation (“NHC”) entered into a Credit Agreement (the “Credit Agreement”) among NHC, as borrower, certain subsidiaries of NHC, as the guarantors, the lenders from time to time party thereto, and Bank of America, N.A. (“Bank of America”), as administrative agent, swingline lender and issuer of letters of credit.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-018604","anchor_url":"https://secwatch.observer/filing/0001437749-26-018604#claim-8cddb5e9fa3ecba1a879949492ceb70b1fd72d29","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926018604/0001437749-26-018604-index.htm"},{"fact_type":"debt_financing","fact_key":"6a78e2d97d299c92ab340c3fc7dab3c75ecbfd3d","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-27T21:13:25+00:00","payload":{"counterparty":"Bank of America, N.A., as administrative agent","effective_date":"2026-05-26","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":"Term SOFR plus 1.50% or base rate plus 0.50%","item_codes_triggered":["2.03"],"maturity_text":"the fifth anniversary of the date of initial funding","principal_text":"$50.0 million"},"claim":"NATIONAL HEALTHCARE CORP incurred revolving credit of $50.0 million with Bank of America, N.A., as administrative agent at Term SOFR plus 1.50% or base rate plus 0.50% maturing the fifth anniversary of the date of initial funding.","evidence_excerpt":"The Credit Agreement provides for (i) a $475.0 million senior unsecured term loan facility (the “Term Loan Facility”) and (ii) a $50.0 million senior unsecured revolving credit facility (the “Revolving Facility,” and together with the Term Loan Facility, the “Credit Facilities”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-018604","anchor_url":"https://secwatch.observer/filing/0001437749-26-018604#claim-6a78e2d97d299c92ab340c3fc7dab3c75ecbfd3d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926018604/0001437749-26-018604-index.htm"},{"fact_type":"debt_financing","fact_key":"065284d49fb9a0c33f1e8f68b393b324a0140115","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-27T21:13:25+00:00","payload":{"counterparty":"Bank of America, N.A., as administrative agent","effective_date":"2026-05-26","event":"incurrence","instrument_type":"term_loan","interest_rate_text":"Term SOFR plus 1.50% or base rate plus 0.50%","item_codes_triggered":["2.03"],"maturity_text":"the fifth anniversary of the date of initial funding","principal_text":"$475.0 million"},"claim":"NATIONAL HEALTHCARE CORP incurred term loan of $475.0 million with Bank of America, N.A., as administrative agent at Term SOFR plus 1.50% or base rate plus 0.50% maturing the fifth anniversary of the date of initial funding.","evidence_excerpt":"The Credit Agreement provides for (i) a $475.0 million senior unsecured term loan facility (the “Term Loan Facility”) and (ii) a $50.0 million senior unsecured revolving credit facility (the “Revolving Facility,” and together with the Term Loan Facility, the “Credit Facilities”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-018604","anchor_url":"https://secwatch.observer/filing/0001437749-26-018604#claim-065284d49fb9a0c33f1e8f68b393b324a0140115","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926018604/0001437749-26-018604-index.htm"},{"fact_type":"material_agreement","fact_key":"28610f7341480453617e2c012aa4d59ae23208b3","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-15T20:04:37+00:00","payload":{"action":"entry","agreement_name":"Purchase and Sale Agreement","agreement_type":"asset_purchase","counterparty":"National Health Corporation","effective_date":"2026-05-14","item_codes_triggered":["1.01"],"value_text":"$50.5 million"},"claim":"NATIONAL HEALTHCARE CORP entered into Purchase and Sale Agreement with National Health Corporation valued at $50.5 million (effective 2026-05-14).","evidence_excerpt":"On May 14, 2026 (the “Effective Date”), NHC/OP, L.P., a Delaware limited partnership (“Buyer”) and a wholly-owned subsidiary of National HealthCare Corporation (“NHC”), entered into a Purchase and Sale Agreement (the “Agreement”) with National Health Corporation, a Tennessee corporation (“Seller”), to purchase from Seller the land, buildings, and other specified assets of Seller’s portfolio of five skilled nursing facilities","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-26-017374","anchor_url":"https://secwatch.observer/filing/0001437749-26-017374#claim-28610f7341480453617e2c012aa4d59ae23208b3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926017374/0001437749-26-017374-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e924592eaa252119e383f9620275fd75d49339ed","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-13T13:57:57+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-07","outcome":"passed","proposal_text":"Advisory vote on the compensation of our Named Executive Officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"18,764","votes_against":"233,276","votes_for":"11,964,538","votes_withheld":null}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Advisory vote on the compensation of our Named Executive Officers at the 2026-05-07 meeting.","evidence_excerpt":"For Against Abstain 11,964,538 233,276 18,764","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-016571","anchor_url":"https://secwatch.observer/filing/0001437749-26-016571#claim-e924592eaa252119e383f9620275fd75d49339ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926016571/0001437749-26-016571-index.htm"},{"fact_type":"shareholder_vote","fact_key":"58a40fa67daeb308ba2d26defccd04d1cff4fd06","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-13T13:57:57+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-07","outcome":"passed","proposal_text":"Re-election of Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams as directors","proposal_type":"director_election","results":[{"broker_non_votes":null,"subject":"Emil E. Hassan","votes_abstain":"18,522","votes_against":null,"votes_for":"11,653,122","votes_withheld":"544,934"},{"broker_non_votes":null,"subject":"Lisa Piercey, M.D.","votes_abstain":"10,092","votes_against":null,"votes_for":"12,176,280","votes_withheld":"30,206"},{"broker_non_votes":null,"subject":"William A. Adams","votes_abstain":"11,990","votes_against":null,"votes_for":"12,190,547","votes_withheld":"14,041"}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Re-election of Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams as directors at the 2026-05-07 meeting.","evidence_excerpt":"For Against Abstain Emil E. Hassan 11,653,122 544,934 18,522 Lisa Piercey, M.D. 12,176,280 30,206 10,092 William A. Adams 12,190,547 14,041 11,990","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-016571","anchor_url":"https://secwatch.observer/filing/0001437749-26-016571#claim-58a40fa67daeb308ba2d26defccd04d1cff4fd06","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926016571/0001437749-26-016571-index.htm"},{"fact_type":"earnings_release","fact_key":"6a7e2e930df400f1120097dde2dd56ce12b48456","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-05-08T23:59:59+00:00","payload":{"eps_text":"$2.27","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$35,857,000","period_text":"the quarter ended March 31, 2026","report_date":"2026-05-08","result_type":"reported_results","revenue_text":"$381,821,000"},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended March 31, 2026 results: revenue $381,821,000, net income $35,857,000, EPS $2.27.","evidence_excerpt":"National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended March 31, 2026 totaled $381,821,000 compared to $373,697,000 for the quarter ended March 31, 2025, an increase of 2.2%. For the quarter ended March 31, 2026, the reported GAAP net income attributable to NHC was $35,857,000 compared to $32,205,000 for the same period in 2025. Excluding the unrealized gains in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended March 31, 2026 was $30,089,000 compared to $24,838,000 for the same period in 2025, an increase of 21.1% (*) . The GAAP diluted earnings per share were $2.27 and $2.07 for the quarters ending March 31, 2026 and 2025, respectively.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-26-015802","anchor_url":"https://secwatch.observer/filing/0001437749-26-015802#claim-6a7e2e930df400f1120097dde2dd56ce12b48456","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926015802/0001437749-26-015802-index.htm"},{"fact_type":"material_agreement","fact_key":"7b1eb7719aa43ac1bc4d0429878cd3fac30fc925","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2026-04-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Purchase and Sale Agreement","agreement_type":"asset_purchase","counterparty":"National Health Investors, Inc.","effective_date":"2026-04-21","item_codes_triggered":["1.01"],"value_text":"$560 million"},"claim":"NATIONAL HEALTHCARE CORP entered into Purchase and Sale Agreement with National Health Investors, Inc. valued at $560 million (effective 2026-04-21).","evidence_excerpt":"On April 21, 2026 (the “Effective Date”), NHC/OP, L.P., a Delaware limited partnership (the “Purchaser”) and a wholly-owned subsidiary of National HealthCare Corporation (“NHC”), on behalf of itself and its affiliates identified in the Agreement, each of which is a wholly-owned subsidiary of NHC (collectively, together with the Purchaser, “we,” “us,” or “our”) entered into a Purchase and Sale Agreement (the “Agreement”) with National Health Investors, Inc. (“NHI”), a publicly-traded real estate investment trust, on behalf of itself and its affiliates identified in the Agreement (collectively, together with NHI, the “Seller Parties”), to purchase from the Seller Parties the land, facilities, and improvements, including 32 skilled nursing facilities and three independent living facilities (collectively, the “Property,” and with respect to the 35 facilities, the “Facilities”), currently leased by us, as tenant, from the Seller Parties, as landlord, under a Master Agreement to Lease dated","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001437749-26-012953","anchor_url":"https://secwatch.observer/filing/0001437749-26-012953#claim-7b1eb7719aa43ac1bc4d0429878cd3fac30fc925","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774926012953/0001437749-26-012953-index.htm"},{"fact_type":"auditor_change","fact_key":"dc061fe864d305034ab0f6a87c7901131820fda9","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2025-04-08T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Ernst & Young LLP","disagreement_text":"no disagreements","effective_date":"2025-04-03","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Deloitte & Touche LLP"},"claim":"NATIONAL HEALTHCARE CORP dismissed Ernst & Young LLP as its auditor.","evidence_excerpt":"approved the appointment of Deloitte & Touche LLP (\"Deloitte\") as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending December 31, 2025 and the dismissal of Ernst & Young LLP (\"EY\") as the Company’s independent registered public accounting firm, in each case, effective as of April 3, 2025.","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001437749-25-011399","anchor_url":"https://secwatch.observer/filing/0001437749-25-011399#claim-dc061fe864d305034ab0f6a87c7901131820fda9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774925011399/0001437749-25-011399-index.htm"},{"fact_type":"auditor_change","fact_key":"d54dfa5c33c0117662a6067d834a33ba6923d898","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2025-04-08T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Deloitte & Touche LLP","disagreement_text":"no disagreements","effective_date":"2025-04-03","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"NATIONAL HEALTHCARE CORP engaged Deloitte & Touche LLP as its auditor.","evidence_excerpt":"approved the appointment of Deloitte & Touche LLP (\"Deloitte\") as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending December 31, 2025 and the dismissal of Ernst & Young LLP (\"EY\") as the Company’s independent registered public accounting firm, in each case, effective as of April 3, 2025.","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001437749-25-011399","anchor_url":"https://secwatch.observer/filing/0001437749-25-011399#claim-d54dfa5c33c0117662a6067d834a33ba6923d898","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774925011399/0001437749-25-011399-index.htm"},{"fact_type":"executive_change","fact_key":"8d385c5d63","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-11-14T23:59:59+00:00","payload":{"action":"retire","action_category":"departure","departure_tone":"retirement","effective_date":"2025-05-08","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"W. Andrew Adams departed as Director at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"On November 7, 2024, W. Andrew Adams notified National HealthCare Corporation (the “Company”) that, after 32 years of service, he intends to retire as a member of the Company Board of Directors (the “Board”) effective at the conclusion of the 2025 annual meeting of shareholders to be held on May 8, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-034983","anchor_url":"https://secwatch.observer/filing/0001437749-24-034983#claim-8d385c5d63","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924034983/0001437749-24-034983-index.htm"},{"fact_type":"ma_transaction","fact_key":"6b4d01e5e015cc1e80391fcb3f380791f99189bf","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-08-06T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2024-07-31","consideration_text":"$221,400,000.00","counterparty":"White Oak Manor, Inc., its corporate subsidiaries, White Oak Pharmacy, Inc., and the other Seller Parties","effective_date":"2024-08-01","item_codes_triggered":["2.01"]},"claim":"NATIONAL HEALTHCARE CORP completed an acquisition involving White Oak Manor, Inc., its corporate subsidiaries, White Oak Pharmacy, Inc., and the other Seller Parties for $221,400,000.00 (closed 2024-07-31).","evidence_excerpt":"Oak home office building in Spartanburg, South Carolina. The purchase price for the Transaction was Two Hundred Twenty-One Million Four Hundred Thousand and 00/100 Dollars ($221,400,000.00), subject to prorations and adjustments as set forth in the Agreement. NHC purchased the name “White Oak,” and derivations thereof, including any logos and trademarks and will","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-24-024854","anchor_url":"https://secwatch.observer/filing/0001437749-24-024854#claim-6b4d01e5e015cc1e80391fcb3f380791f99189bf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924024854/0001437749-24-024854-index.htm"},{"fact_type":"executive_change","fact_key":"93e156d926","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-07-11T23:59:59+00:00","payload":{"action":"retire","action_category":"departure","departure_tone":"retirement","effective_date":"2024-07-31","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Ernest G. Burgess, III departed as Director at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"On July 8, 2024, Ernest G. Burgess, III, an NHC director since 1997, notified the Company that he intends to retire from the Board effective July 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-022577","anchor_url":"https://secwatch.observer/filing/0001437749-24-022577#claim-93e156d926","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924022577/0001437749-24-022577-index.htm"},{"fact_type":"shareholder_vote","fact_key":"91a68d60816255107fff4efdc7b276d3bac62b1e","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-05-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Advisory vote on the compensation of Named Executive Officers","proposal_type":"say_on_pay","votes_abstain_text":"23,691","votes_against_text":"206,294","votes_for_text":"12,356,288"},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Advisory vote on the compensation of Named Executive Officers at the 2024-05-09 meeting.","evidence_excerpt":"For Against Abstain 12,356,288 206,294 23,691 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001437749-24-016722","anchor_url":"https://secwatch.observer/filing/0001437749-24-016722#claim-91a68d60816255107fff4efdc7b276d3bac62b1e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924016722/0001437749-24-016722-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3137a73c41c70562f1ef45d15bf38e2fe3d0602c","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-05-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Re-election of Robert G. Adams as director","proposal_type":"director_election","votes_abstain_text":"4,801","votes_against_text":"823,901","votes_for_text":"11,757,571"},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Re-election of Robert G. Adams as director at the 2024-05-09 meeting.","evidence_excerpt":"Adams 11,757,571 823,901 4,801 2.         To consider an advisory vote on the compensation of our Named Executive Officers.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-016722","anchor_url":"https://secwatch.observer/filing/0001437749-24-016722#claim-3137a73c41c70562f1ef45d15bf38e2fe3d0602c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924016722/0001437749-24-016722-index.htm"},{"fact_type":"shareholder_vote","fact_key":"db883ee390383b391a7137561d8e176d34c46c1f","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-05-15T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Re-election of J. Paul Abernathy, M.D. as director","proposal_type":"director_election","votes_abstain_text":"26,773","votes_against_text":"3,588,572","votes_for_text":"8,970,928"},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Re-election of J. Paul Abernathy, M.D. as director at the 2024-05-09 meeting.","evidence_excerpt":"8,970,928 3,588,572 26,773 Robert G. Adams 11,757,571 823,901 4,801 2.         To consider an advisory vote on the compensation of our Named Executive Officers.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-016722","anchor_url":"https://secwatch.observer/filing/0001437749-24-016722#claim-db883ee390383b391a7137561d8e176d34c46c1f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924016722/0001437749-24-016722-index.htm"},{"fact_type":"earnings_release","fact_key":"4ebe8b22988c4928236036ca96cfdee52b89c845","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-05-10T23:59:59+00:00","payload":{"eps_text":"$1.69","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$26,213,000","period_text":"the quarter ended March 31, 2024","report_date":"2024-05-10","result_type":"reported_results","revenue_text":"$297,176,000"},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended March 31, 2024 results: revenue $297,176,000, net income $26,213,000, EPS $1.69.","evidence_excerpt":"(NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended March 31, 2024 totaled $297,176,000 compared to $269,563,000 for the quarter ended March 31, 2023, an increase of 10.2%. For the quarter ended March 31, 2024, the reported GAAP net income attributable to NHC was","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-24-015875","anchor_url":"https://secwatch.observer/filing/0001437749-24-015875#claim-4ebe8b22988c4928236036ca96cfdee52b89c845","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924015875/0001437749-24-015875-index.htm"},{"fact_type":"earnings_release","fact_key":"8c358a93dda3723730b5b1bcdb98d61a7b3ec67d","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-02-16T23:59:59+00:00","payload":{"eps_text":"$1.83","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$28,406,000","period_text":"the quarter ended December 31, 2023","report_date":"2024-02-16","result_type":"reported_results","revenue_text":null},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended December 31, 2023 results: net income $28,406,000, EPS $1.83.","evidence_excerpt":"For the quarter ended December 31, 2023, the reported GAAP net income attributable to NHC was $28,406,000 compared to $6,353,000 for the same period in 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-24-004621","anchor_url":"https://secwatch.observer/filing/0001437749-24-004621#claim-8c358a93dda3723730b5b1bcdb98d61a7b3ec67d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924004621/0001437749-24-004621-index.htm"},{"fact_type":"earnings_release","fact_key":"fb59c693dda259c7e5e8ac9e5f8555df6ecd0da4","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2024-02-16T23:59:59+00:00","payload":{"eps_text":"$4.34","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$66,798,000","period_text":"the year ended December 31, 2023","report_date":"2024-02-16","result_type":"reported_results","revenue_text":"$1,141,544,000"},"claim":"NATIONAL HEALTHCARE CORP reported the year ended December 31, 2023 results: revenue $1,141,544,000, net income $66,798,000, EPS $4.34.","evidence_excerpt":"announced today net operating revenues and grant income for the year ended December 31, 2023 totaled $1,141,544,000 compared to $1,085,738,000 for the year ended December 31, 2022, an increase of 5.1%.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-24-004621","anchor_url":"https://secwatch.observer/filing/0001437749-24-004621#claim-fb59c693dda259c7e5e8ac9e5f8555df6ecd0da4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774924004621/0001437749-24-004621-index.htm"},{"fact_type":"earnings_release","fact_key":"20113e202a5d3e873f4857e02455a8f7aafd5411","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-11-03T23:59:59+00:00","payload":{"eps_text":"$0.68","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$10,388,000","period_text":"the quarter ended September 30, 2023","report_date":"2023-11-03","result_type":"reported_results","revenue_text":"$288,485,000"},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended September 30, 2023 results: revenue $288,485,000, net income $10,388,000, EPS $0.68.","evidence_excerpt":"National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2023 totaled $288,485,000 compared to $270,843,000 for the quarter ended September 30, 2022, an increase of 6.5%.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-030139","anchor_url":"https://secwatch.observer/filing/0001437749-23-030139#claim-20113e202a5d3e873f4857e02455a8f7aafd5411","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923030139/0001437749-23-030139-index.htm"},{"fact_type":"shareholder_vote","fact_key":"01096eb1f1bf9cffdd4a102a087228d5016ce1c8","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-08-07T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-04","outcome":"passed","proposal_text":"Advisory vote on frequency of advisory vote on compensation of named executive officers","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"14,880","votes_against":null,"votes_for":"6,828,879","votes_withheld":null}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Advisory vote on frequency of advisory vote on compensation of named executive officers at the 2023-05-04 meeting.","evidence_excerpt":"One Year Two Years Three Years Abstain 6,828,879 712,763 4,727,901 14,880","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-23-022253","anchor_url":"https://secwatch.observer/filing/0001437749-23-022253#claim-01096eb1f1bf9cffdd4a102a087228d5016ce1c8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923022253/0001437749-23-022253-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d31609fc69f2685d83729cc17ae06f24d701a281","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-08-07T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-04","outcome":"passed","proposal_text":"Advisory vote on compensation of named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"67,358","votes_against":"688,231","votes_for":"11,528,834","votes_withheld":null}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Advisory vote on compensation of named executive officers at the 2023-05-04 meeting.","evidence_excerpt":"To consider an advisory vote on the compensation of our named executive officers. For Against Abstain 11,528,834 688,231 67,358","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-23-022253","anchor_url":"https://secwatch.observer/filing/0001437749-23-022253#claim-d31609fc69f2685d83729cc17ae06f24d701a281","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923022253/0001437749-23-022253-index.htm"},{"fact_type":"shareholder_vote","fact_key":"8bdb14efd2d176762c4ce212a74b73da5312228d","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-08-07T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-04","outcome":"passed","proposal_text":"Election of W. Andrew Adams, Ernest G. Burgess, III, and Emil E. Hassan as directors","proposal_type":"director_election","results":[{"broker_non_votes":null,"subject":"W. Andrew Adams","votes_abstain":"9,144","votes_against":null,"votes_for":"7,667,972","votes_withheld":"4,607,307"},{"broker_non_votes":null,"subject":"Ernest G. Burgess, III","votes_abstain":"4,420","votes_against":null,"votes_for":"8,341,606","votes_withheld":"3,938,397"},{"broker_non_votes":null,"subject":"Emil E. Hassan","votes_abstain":"11,248","votes_against":null,"votes_for":"9,233,067","votes_withheld":"3,040,108"}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved Election of W. Andrew Adams, Ernest G. Burgess, III, and Emil E. Hassan as directors at the 2023-05-04 meeting.","evidence_excerpt":"For Against Abstain W. Andrew Adams 7,667,972 4,607,307 9,144 Ernest G. Burgess, III 8,341,606 3,938,397 4,420 Emil E. Hassan 9,233,067 3,040,108 11,248","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-23-022253","anchor_url":"https://secwatch.observer/filing/0001437749-23-022253#claim-8bdb14efd2d176762c4ce212a74b73da5312228d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923022253/0001437749-23-022253-index.htm"},{"fact_type":"earnings_release","fact_key":"1c6a8e037d398863b206b1038321f1ad0b2c85df","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-08-04T23:59:59+00:00","payload":{"eps_text":"$1.06","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$16,281,000","period_text":"the quarter ended June 30, 2023","report_date":"2023-08-04","result_type":"reported_results","revenue_text":"$282,582,000"},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended June 30, 2023 results: revenue $282,582,000, net income $16,281,000, EPS $1.06.","evidence_excerpt":"net operating revenues and grant income for the quarter ended June 30, 2023 totaled $282,582,000","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001437749-23-022076","anchor_url":"https://secwatch.observer/filing/0001437749-23-022076#claim-1c6a8e037d398863b206b1038321f1ad0b2c85df","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923022076/0001437749-23-022076-index.htm"},{"fact_type":"executive_change","fact_key":"448e686d43","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-26T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2023-05-31","interim":false,"role":"Senior Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Brian F. Kidd was appointed as Senior Vice President and Chief Financial Officer at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"Mr. Kidd’s title will change to “Senior Vice President and Chief Financial Officer” effective May 31, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-015974","anchor_url":"https://secwatch.observer/filing/0001437749-23-015974#claim-448e686d43","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923015974/0001437749-23-015974-index.htm"},{"fact_type":"executive_change","fact_key":"232fe1680f","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-26T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2023-05-31","interim":false,"role":"Senior Vice President and Treasurer","role_category":"other_named_officer","successor_name":"Brian F. Kidd","successor_named":true},"claim":"Jeffrey R. Smith retired as Senior Vice President and Treasurer at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"Jeffrey R. Smith, Senior Vice President and Treasurer, announced his intent to retire from the Company effective on May 31, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-015974","anchor_url":"https://secwatch.observer/filing/0001437749-23-015974#claim-232fe1680f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923015974/0001437749-23-015974-index.htm"},{"fact_type":"executive_change","fact_key":"2dc10b29f8","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-12T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2023-05-31","interim":false,"role":"Senior Vice President and Treasurer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jeffrey R. Smith retired as Senior Vice President and Treasurer at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"Jeffrey R. Smith, Senior Vice President and Treasurer, has announced that he plans to retire from the Company effective on May 31, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-014232","anchor_url":"https://secwatch.observer/filing/0001437749-23-014232#claim-2dc10b29f8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923014232/0001437749-23-014232-index.htm"},{"fact_type":"material_agreement","fact_key":"e741906e81fa946cea51ec97107c9a97a1047067","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-11T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Revolving Credit Loan Agreement","agreement_type":"credit_facility","counterparty":"Pinnacle Bank","effective_date":"2023-05-10","item_codes_triggered":["1.01"],"value_text":"$50,000,000"},"claim":"NATIONAL HEALTHCARE CORP entered into Revolving Credit Loan Agreement with Pinnacle Bank valued at $50,000,000 (effective 2023-05-10).","evidence_excerpt":"On May 10, 2023, National HealthCare Corporation (“NHC”) entered into a Revolving Credit Loan Agreement (the “Credit Agreement”) with Pinnacle Bank, as lender (the “Lender”). The Credit Agreement provides for a $50,000,000 revolving credit facility with a one-year term (the “Credit Facility”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-23-013818","anchor_url":"https://secwatch.observer/filing/0001437749-23-013818#claim-e741906e81fa946cea51ec97107c9a97a1047067","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923013818/0001437749-23-013818-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d7287f54c62ebb4361293ed4c9435ffd576b87a2","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-04","outcome":"passed","proposal_text":"To consider an advisory vote on the frequency of the advisory vote on compensation of our named executive officers.","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"14,880","votes_against":"0","votes_for":"6,828,879","votes_withheld":"0"}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved To consider an advisory vote on the frequency of the advisory vote on compensation of our named executive officers. at the 2023-05-04 meeting.","evidence_excerpt":"To consider an advisory vote on the frequency of the advisory vote on compensation of our named executive officers. One Year Two Years Three Years Abstain 6,828,879 712,763 4,727,901 14,880","confidence":0.88,"filing_url":"https://secwatch.observer/filing/0001437749-23-013160","anchor_url":"https://secwatch.observer/filing/0001437749-23-013160#claim-d7287f54c62ebb4361293ed4c9435ffd576b87a2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923013160/0001437749-23-013160-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9fc3f5bd0e2a73ab39bff4797e456a4383c8cd93","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-04","outcome":"passed","proposal_text":"To consider an advisory vote on the compensation of our named executive officers.","proposal_type":"say_on_pay","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"67,358","votes_against":"688,231","votes_for":"11,528,834","votes_withheld":"0"}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved To consider an advisory vote on the compensation of our named executive officers. at the 2023-05-04 meeting.","evidence_excerpt":"To consider an advisory vote on the compensation of our named executive officers. For Against Abstain 11,528,834 688,231 67,358","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-013160","anchor_url":"https://secwatch.observer/filing/0001437749-23-013160#claim-9fc3f5bd0e2a73ab39bff4797e456a4383c8cd93","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923013160/0001437749-23-013160-index.htm"},{"fact_type":"shareholder_vote","fact_key":"b99736a560f51ab2d7e4017c19dad16ca7b857f5","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-04","outcome":"passed","proposal_text":"The Re-election of W. Andrew Adams, Ernest G. Burgess, III, and Emil E. Hassan as directors to each hold office for a three (3) year term and until their successors have been duly elected and qualified","proposal_type":"director_election","results":[{"broker_non_votes":"0","subject":"W. Andrew Adams","votes_abstain":"9,144","votes_against":"4,607,307","votes_for":"7,667,972","votes_withheld":"0"},{"broker_non_votes":"0","subject":"Ernest G. Burgess, III","votes_abstain":"4,420","votes_against":"3,938,397","votes_for":"8,341,606","votes_withheld":"0"},{"broker_non_votes":"0","subject":"Emil E. Hassan","votes_abstain":"11,248","votes_against":"3,040,108","votes_for":"9,233,067","votes_withheld":"0"}]},"claim":"NATIONAL HEALTHCARE CORP shareholders approved The Re-election of W. Andrew Adams, Ernest G. Burgess, III, and Emil E. Hassan as directors to each hold office for a three (3) year term and until their successors have been duly elected and qualified at the 2023-05-04 meeting.","evidence_excerpt":"The Re-election of W. Andrew Adams, Ernest G. Burgess, III, and Emil E. Hassan as directors to each hold office for a three (3) year term and until their successors have been duly elected and qualified; For Against Abstain W. Andrew Adams 7,667,972 4,607,307 9,144 Ernest G. Burgess, III 8,341,606 3,938,397 4,420 Emil E. Hassan 9,233,067 3,040,108 11,248","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-013160","anchor_url":"https://secwatch.observer/filing/0001437749-23-013160#claim-b99736a560f51ab2d7e4017c19dad16ca7b857f5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923013160/0001437749-23-013160-index.htm"},{"fact_type":"earnings_release","fact_key":"82a92e6f00df59cb6580a89ceb0f5eb7af0f7d0b","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-05-05T23:59:59+00:00","payload":{"eps_text":"$0.76","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$11,723,000","period_text":"the quarter ended March 31, 2023","report_date":"2023-05-05","result_type":"reported_results","revenue_text":"$269,563,000"},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended March 31, 2023 results: revenue $269,563,000, net income $11,723,000, EPS $0.76.","evidence_excerpt":"NHC Reports First Quarter 2023 Earnings MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC ), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended March 31, 2023 totaled $269,563,000 compared to $278,983,000 for the quarter ended March 31, 2022, a decrease of 3.4%.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-23-012716","anchor_url":"https://secwatch.observer/filing/0001437749-23-012716#claim-82a92e6f00df59cb6580a89ceb0f5eb7af0f7d0b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923012716/0001437749-23-012716-index.htm"},{"fact_type":"earnings_release","fact_key":"168014cf70dda16cd3cc79484ad3c31ee4fc3acb","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-02-17T23:59:59+00:00","payload":{"eps_text":"$0.41","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$6,353,000","period_text":"the quarter ended December 31, 2022","report_date":"2023-02-17","result_type":"reported_results","revenue_text":null},"claim":"NATIONAL HEALTHCARE CORP reported the quarter ended December 31, 2022 results: net income $6,353,000, EPS $0.41.","evidence_excerpt":"For the quarter ended December 31, 2022, the reported GAAP net income attributable to NHC was $6,353,000 compared to $15,788,000 for the same period in 2021.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-23-003759","anchor_url":"https://secwatch.observer/filing/0001437749-23-003759#claim-168014cf70dda16cd3cc79484ad3c31ee4fc3acb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923003759/0001437749-23-003759-index.htm"},{"fact_type":"earnings_release","fact_key":"96cdd05cbb77bada8eb0127814a61d2bd7f276b3","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2023-02-17T23:59:59+00:00","payload":{"eps_text":"$1.45","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$22,445,000","period_text":"the year ended December 31, 2022","report_date":"2023-02-17","result_type":"reported_results","revenue_text":"$1,085,738,000"},"claim":"NATIONAL HEALTHCARE CORP reported the year ended December 31, 2022 results: revenue $1,085,738,000, net income $22,445,000, EPS $1.45.","evidence_excerpt":"National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the year ended December 31, 2022 totaled $1,085,738,000 compared to $1,074,302,000 for the year ended December 31, 2021, an increase of 1.1%.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-23-003759","anchor_url":"https://secwatch.observer/filing/0001437749-23-003759#claim-96cdd05cbb77bada8eb0127814a61d2bd7f276b3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774923003759/0001437749-23-003759-index.htm"},{"fact_type":"earnings_release","fact_key":"331f570b9bff1484636ad4c6c4f41bea2896f47f","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2022-11-04T23:59:59+00:00","payload":{"eps_text":"$0.16","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$2,429,000","period_text":"quarter ended September 30, 2022","report_date":"2022-11-03","result_type":"reported_results","revenue_text":"$270,843,000"},"claim":"NATIONAL HEALTHCARE CORP reported quarter ended September 30, 2022 results: revenue $270,843,000, net income $2,429,000, EPS $0.16.","evidence_excerpt":"oldest publicly traded senior health care company, announced today net operating revenues and government stimulus income for the quarter ended September 30, 2022 totaled $270,843,000 compared to $276,737,000 for the quarter ended September 30, 2021, a decrease of 2.1%. The net operating revenues decrease during the third quarter of 2022 was primarily driven by","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001437749-22-025966","anchor_url":"https://secwatch.observer/filing/0001437749-22-025966#claim-331f570b9bff1484636ad4c6c4f41bea2896f47f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774922025966/0001437749-22-025966-index.htm"},{"fact_type":"executive_change","fact_key":"65d758b1b5","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2022-02-16T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-02-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Sandra Y. Trail was appointed as Director at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"appointed Ms. Sandra Y. Trail to fill the resulting vacancy as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-22-003459","anchor_url":"https://secwatch.observer/filing/0001437749-22-003459#claim-65d758b1b5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774922003459/0001437749-22-003459-index.htm"},{"fact_type":"executive_change","fact_key":"cb2d49251d","cik":1047335,"ticker":"NHC","company_name":"NATIONAL HEALTHCARE CORP","filed_at":"2022-01-28T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-02-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Sandra Y. Trail was appointed as Director at NATIONAL HEALTHCARE CORP.","evidence_excerpt":"appointed Ms. Sandra Y. Trail to fill the resulting vacancy as of the Effective Date.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001437749-22-001891","anchor_url":"https://secwatch.observer/filing/0001437749-22-001891#claim-cb2d49251d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1047335/000143774922001891/0001437749-22-001891-index.htm"}]}